1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …

Obstructive sleep apnea (OSA) is thought to affect almost 1 billion people worldwide. OSA
has well established cardiovascular and neurocognitive sequelae, although the optimal …

Obstructive sleep apnea (OSA) is a condition caused by repeated episodes of upper airway
collapse and obstruction during sleep associated with arousal from sleep with or without …

Cardiovascular disease (CVD) remains a highly prevalent cause of morbidity and mortality,
both in the United States and worldwide. In parallel with the development of new and …

Rationale: Symptom subtypes have been described in clinical and population samples of
patients with obstructive sleep apnea (OSA). It is unclear whether these subtypes have …

Obstructive Sleep Apnea Syndrome (OSAS) is a respiratory sleep disorder characterised by
repeated episodes of partial or complete obstruction of the upper airway during the night …

Identification of obstructive sleep apnea and risk factors is important for reduction in
symptoms and cardiovascular risk, and for improvement of quality of life. The population …

The prevalence of obstructive sleep apnea (OSA) defined at an apnea-hypopnea index
(AHI)≥ 5 was a mean of 22%(range, 9-37%) in men and 17%(range, 4-50%) in women in …

Obstructive sleep apnea (OSA) is a serious, potentially life-threatening condition.
Epidemiologic studies show that sleep apnea increases cardiovascular diseases risk factors …

Background Increased mortality has been reported in people with insomnia and in those
with obstructive sleep apnoea (OSA). However, these conditions commonly co-occur and …